Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2019 2
2020 2
2022 5
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcomes of extraskeletal Ewing sarcoma.
Houdek MT, Heidenreich MJ, Ahmed SK, Allen-Rhoades W, Siontis BL, Robinson SI, Petersen IA, Rose PS. Houdek MT, et al. Among authors: siontis bl. J Surg Oncol. 2023 Jul;128(1):105-110. doi: 10.1002/jso.27250. Epub 2023 Mar 31. J Surg Oncol. 2023. PMID: 36999583
Current clinical management of primary cardiac sarcoma.
Siontis BL, Leja M, Chugh R. Siontis BL, et al. Expert Rev Anticancer Ther. 2020 Jan;20(1):45-51. doi: 10.1080/14737140.2020.1711738. Epub 2020 Jan 9. Expert Rev Anticancer Ther. 2020. PMID: 31914831 Review.
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study.
Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML, Ruiz-Soto R, Heinrich MC, Bauer S; INTRIGUE investigators. Gelderblom H, et al. Among authors: siontis bl. Eur J Cancer. 2023 Oct;192:113245. doi: 10.1016/j.ejca.2023.113245. Epub 2023 Jul 20. Eur J Cancer. 2023. PMID: 37598656 Free article. Clinical Trial.
Not All Leiomyosarcomas Are the Same: How to Best Classify LMS.
Hickman A, Siontis BL. Hickman A, et al. Among authors: siontis bl. Curr Treat Options Oncol. 2023 Apr;24(4):327-337. doi: 10.1007/s11864-023-01067-2. Epub 2023 Mar 8. Curr Treat Options Oncol. 2023. PMID: 36884163 Review.
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
Heinrich MC, Jones RL, George S, Gelderblom H, Schöffski P, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Reichmann W, Sprott K, Achour H, Sherman ML, Ruiz-Soto R, Blay JY, Bauer S. Heinrich MC, et al. Among authors: siontis bl. Nat Med. 2024 Feb;30(2):498-506. doi: 10.1038/s41591-023-02734-5. Epub 2024 Jan 5. Nat Med. 2024. PMID: 38182785 Free PMC article. Clinical Trial.
Primary Pancreatic Undifferentiated Pleomorphic Sarcoma.
Patel MH, Guerrero Vinsard D, Agrawal U, Kendziora RW, Siontis BL, Swaroop Vege S, Sweetser S. Patel MH, et al. Among authors: siontis bl. ACG Case Rep J. 2023 Mar 22;10(3):e01011. doi: 10.14309/crj.0000000000001011. eCollection 2023 Mar. ACG Case Rep J. 2023. PMID: 36968124 Free PMC article.
22 results